TEDA BIOMEDICAL signed a strategic cooperation agreement with Suihonghua in the field of AI medical health
TEDA BIOMEDICAL and Suihonghua Technology signed a strategic cooperation agreement in the field of AI medical health. Both parties will leverage their respective resources and technological advantages to promote the specialized operation and market promotion of AI medical health and data businesses. The cooperation will focus on the construction of intelligent computing centers, computing power provision, and hardware solutions to support the research and commercialization of AI medical large models. The board believes that this cooperation will achieve complementary advantages in resources and technology, helping the business to quickly reach the market and reduce promotion costs
According to the Zhitong Finance APP, TEDA Biomedical (08189) announced that the company recently signed a strategic cooperation agreement in the field of AI medical health with Shanghai Suihong Huachuang Technology Co., Ltd. (Suihong Huachuang), a subsidiary of Xiamen Hongxin Electronic Technology Group Co., Ltd. (stock code: 300657), which is listed on the A-share market. Both parties will fully leverage their respective resources, talents, and technological advantages to establish long-term strategic cooperation in specialized operations and market promotion of AI medical health and data businesses, the construction of intelligent computing centers in the medical health field, the provision of computing power, and the overall solutions for diverse heterogeneous computing power hardware.
Currently, the group is fully promoting the research and commercialization of AI medical large model business and related data business. Among them, high-quality computing power resources, stable hardware solutions, and broad market promotion channels are key elements supporting the efficient development of the above businesses. To ensure the sustainable and steady advancement of the business, the company will actively carry out resource docking and cooperation negotiations around these key directions to provide solid support for the long-term development of the business.
The board of directors believes that by signing the strategic cooperation agreement with Suihong Huachuang, the advantages of both parties' resources and technologies can be complementary: first, leveraging Suihong Huachuang's accumulated government cooperation and mature sales channels in the construction of intelligent computing centers and the production of computing power servers can provide direct and strong support for the market promotion of the company's AI medical large model and related data businesses, helping the business quickly reach the target market; second, utilizing Suihong Huachuang's core technological capabilities in AI computing power infrastructure construction, intelligent computing center operation, and hardware production can provide stable and efficient computing power support and cost-effective hardware solutions for the training optimization and practical application of the company's AI medical large model, effectively reducing the cost of business advancement and accelerating the transformation and landing process of the company's related technological achievements into commercial applications
